New York Life Investment Management’s Ginkgo Bioworks DNA Stock Holding History

New York Life Investment Management’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-530	Closed	-$38.3K	–	1316
2023 Q3	$38.3K	Sell	530 -152	-22%	-$12.2K	﹤0.01%	1295
2023 Q2	$50.7K	Sell	682 -726	-52%	-$43K	﹤0.01%	1306
2023 Q1	$74.9K	Sell	1,408 -408	-22%	-$25.9K	﹤0.01%	1197
2022 Q4	$123K	Buy	1,816 +833	+85%	+$76.6K	﹤0.01%	1188
2022 Q3	$123K	Buy	983 +244	+33%	+$29.1K	﹤0.01%	1199
2022 Q2	$71K	Buy	+739	New	+$90.1K	﹤0.01%	1247

Other funds holding DNA

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACG

Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

New York Life Investment Management's DNA Position: Q4 2023 in Review

New York Life Investment Management sold out of Ginkgo Bioworks (DNA) in Q4 2023, closing a stake of 530 shares — an estimated $38.3K sold.

New York Life Investment Management first reported a position in DNA in Q2 2022 and held it in 6 quarters. The position peaked at $123K in Q3 2022. 342 funds tracked by Wall St. Rank hold DNA as of Q4 2023.

New York Life Investment Management reported no remaining Ginkgo Bioworks position as of Q4 2023 after selling out during the quarter.
New York Life Investment Management sold 530 Ginkgo Bioworks shares in Q4 2023, an estimated $38.3K.
New York Life Investment Management first reported a position in Ginkgo Bioworks in Q2 2022 and held it in 6 quarters.
New York Life Investment Management's Ginkgo Bioworks position peaked at $123K in Q3 2022.
342 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2023.

Based on New York Life Investment Management's 13F filing for Q4 2023, filed 6 Feb 2024.